Clinical Application of Cholangiojejunostomy in the Surgical Treatment of Cholelithiasis With Moderate Dilatation of Common Bile Duct
NCT ID: NCT02915770
Last Updated: 2016-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1 participants
INTERVENTIONAL
2015-12-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese Registry Study on Treatment of Cholecysto-Choledocholithiasis
NCT02554097
Comparison of Two Kinds of Biliary Intestinal Reconstruction in Cholangiectasia
NCT03401424
Safety and Feasibility of Early T-tube Cholangiography Performed Within 2 to 3 Days After Laparoscopic Common Bile Duct Exploration
NCT07058740
Cholecystectomy First vs Sequential Common Bile Duct Imaging + Cholecystectomy
NCT01492790
Study of Abdominal Drainage in LCBDE+PC
NCT03120754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
participants receive cholangiojejunostomy
participants will receive hepatectomy、cholangiojejunostomy and T-tube Drainage
cholangiojejunostomy
Half of participants will receive hepatectomy, cholangiojejunostomy and T-tube Drainage,while the other half will receive hepatectomy and T-tube Drainage
hepatectomy
T-tube
T-tube Drainage
participants receive no cholangiojejunostomy
participants will receive hepatectomy and T-tube Drainage
hepatectomy
T-tube
T-tube Drainage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cholangiojejunostomy
Half of participants will receive hepatectomy, cholangiojejunostomy and T-tube Drainage,while the other half will receive hepatectomy and T-tube Drainage
hepatectomy
T-tube
T-tube Drainage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No residual stones in the operation
* Extrahepatic bile duct dilatation, 15-30 mm in diam.
* No relaxation or stenosis of the sphincter of Oddi
Exclusion Criteria
* Surgical treatment can not be performed because of various reasons.
* Intrahepatic and extrahepatic bile duct stones can not be taken away
* with other biliary tract diseases, such as bile duct cancer
* Oddi sphincter relaxation or stenosis
* loss to follow-up
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Southwest Hospital, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dajiang li
associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hepatobiliary Surgery Institute, Southwest Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014（18）
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.